Lidothol Es System
NDC Package 87063-323-15

11-digit billing NDC: 87063032315
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Lidothol Es (menthol 5%, lidocaine 4%) systems is lidothol® ES is a formulation used to assist patients in the treatment of mild to moderate acute or chronic aches or pain. This formulation utilizes a system delivery system. Marketed by Asclemed Usa Inc., this product is identified by NDC 87063-323.

Identification & Billing

NDC Package Code
87063-323-15
Package Description
15 POUCH in 1 BOX / 1 PATCH in 1 POUCH / 1.38 g in 1 PATCH
Product Code
87063-323
11-Digit Billing Format
87063032315

Clinical Specifications

Proprietary Name
Lidothol Es
Non-Proprietary Name
Menthol 5%, Lidocaine 4%
Substance Name
Lidocaine; Menthol
Dosage Form
System -
Administration Route
Transdermal - Administration through the dermal layer of the skin to the systemic circulation by diffusion.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Lidothol® ES is a formulation used to assist patients in the treatment of mild to moderate acute or chronic aches or pain. Muscle or joint pain can be due to muscle or ligament strains, simple backache, tendonitis, osteoarthritis, rheumatoid arthritis, peripheral neuropathies such as diabetic neuropathy or post-herpetic neuralgia, and other complex regional pains. It can also be used to help with certain types of headaches, but use with caution when applying in order to avoid eye contact. Other uses may be considered if deemed clinically relevant.

Regulatory & Marketing

Labeler Name
Asclemed Usa Inc.
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
01-06-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87063-323-15 identifies a specific commercial package of 15 pouch in 1 box / 1 patch in 1 pouch / 1.38 g in 1 patch of Lidothol Es, a human prescription drug labeled by Asclemed Usa Inc.. This system is formulated for transdermal use and contains lidocaine; menthol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Asclemed Usa Inc. on January 06, 2026. The current certification is valid through December 31, 2027.

How is this Asclemed Usa Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87063032315. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87063-323-15
11-Digit CMS (5-4-2)
87063-0323-15

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.